Transgenic restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high-fat-fed mice
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The catabasis of inflammation is an active process directed by n-3 derived pro-resolving lipid mediators. We aimed to determine whether high-fat (HF) diet-induced n-3 deficiency compromises the resolution capacity of obese mice and thereby contributes to obesity-linked inflammation and insulin resistance. RESEARCH DESIGN AND METHODS: We used transgenic expression of the fat-1 n-3 fatty acid desaturase from C. elegans to endogenously restore n-3 fatty acids in HF-fed mice. After 8 weeks on HF or chow diets, wild-type and fat-1 transgenic mice were subjected to insulin and glucose tolerance tests and a resolution assay was performed. Metabolic tissues were then harvested for biochemical analyses. RESULTS: We report that the n-3 docosanoid resolution mediator protectin D1 is lacking in muscle and adipose tissue of HF-fed wild-type mice. Accordingly, HF-fed wild-type mice have an impaired capacity to resolve an acute inflammatory response and display elevated adipose macrophage accrual and chemokine/cytokine expression. This is associated with insulin resistance and higher activation of iNOS and JNK in muscle and liver. These defects are reversed in HF-fed fat-1 mice, in which the biosynthesis of this important n-3 docosanoid resolution mediator is improved. Importantly, transgenic restoration of n-3 fatty acids prevented obesity-linked inflammation and insulin resistance in HF-fed mice without altering food intake, weight gain, or adiposity. CONCLUSIONS: We conclude that inefficient biosynthesis of n-3 resolution mediators in muscle and adipose tissue contributes to the maintenance of chronic inflammation in obesity and that these novel lipids offer exciting potential for the treatment of insulin resistance and diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![FIG. 1. HF feeding reduces n-3 availability for resolution mediator synthesis. A: 8 weeks of HF feeding raised but fat-1 (F1) transgenesis restored the long-chain n-6:n-3 ratio in membrane phospholipids of muscle, liver, and epididymal adipose tissue. C, standard laboratory chow; AA, arachidonic acid (20:4 n-6); EPA, eicosapentaenoic acid (20:5 n-3); DPA, docosapentaenoic acid (22:5 n-3); DHA, docosahexaenoic acid (22:6 n-3). Data are mean ± SEM (n = 3). **P < 0.01 versus WTC; ***P < 0.001 versus WTC; †P < 0.05 versus WTHF; ††P < 0.01 versus WTHF. B: Comparison of n-3 docosanoid and eicosanoid biosynthetic pathways by LC-MS/MS in muscle, liver, and epididymal adipose tissue of HF-fed mice revealed that the docosanoid biosynthetic pathway has greater flux in metabolic tissues. Above left schematic diagram of docosanoid biosynthetic pathway showing the biosynthetic marker 17-HDoHE and PD1 (10R,17S-dihydroxydocosa-4Z,7Z,11E,13E,15Z,19Z-hexaenoic acid [28]) as well as the immediate PD1 precursor 17-HpDoHE. At right, the eicosanoid pathway showing 18-HEPE and RvE1 (5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-EPA [29]). ND indicates not detected. Data are mean ± SEM (n = 9–14). *P < 0.05, **P < 0.01, ***P < 0.001 versus 17-HDoHE. C: Representative LC-MS/MS spectra for 17-HDoHE, PD1, and 18-HEPE; retention times were 22.6, 18.2, and 20.6 min, respectively. D: Comparison of n-3 docosanoid and eicosanoid biosynthetic pathway activity by LC-MS/MS in muscle, liver, and epididymal adipose tissue of HF-fed wild-type and F1 mice reveals increased levels of docosanoid resolution mediator synthesis in muscle and adipose tissue of F1 mice compared with wild-type mice. Data are mean ± SEM (n = 6–10). *P < 0.05 versus WTHF. (A high-quality color representation of this figure is available in the online issue.)](https://figures.cochat.ai/paper-figures/30ad9df130664140a877cc8cc6a3d230/transgenic-restoration-of-long-chain-n-3-fatty-acids-in-insulin-target-tissues-figure-1.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fat-1 mice were also protected from obesity related inflammatory activity and decrements in insulin sensitivity [47].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 2×
“Furthermore, it is critical to determine whether n-3 lipid mediators regulate key obesity-related inflammatory reactions such as macrophage accrual in adipose tissue or activation of inflammatory signaling molecules such as JNK and iNOS that play a role in the etiology of insulin resistance (1,2).”
BackgroundXu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760 · cited 1×
“HF-fed obese mice exhibited an impaired capacity to resolve an acute inflammatory response to TNF and showed abundant macrophage infiltration in adipose tissue that was linked to heightened chemokine and cytokine expression, a hallmark of obesity-linked inflammation (18,19).”
BackgroundMutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 11×
“Our data further suggest that restoring long-chain n-3 PUFAs also prevents obesity-linked insulin resistance by blunting lipid-induced JNK and iNOS activation in muscle and liver.”
BackgroundInfluentialKim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Cinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A. S., & Obin, M. S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500294-jlr200 · Cited by 2,529
Lipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453 · cited 1×
“To test this, we subjected mice to a dorsal air-pouch TNF challenge, an established model of self-resolving inflammation (13).”
MethodResolvin E1 and protectin D1 activate inflammation-resolution programmes
Schwab, J. M., Chiang, N., Arita, M., & Serhan, C. N. (2007) · Nature · doi:10.1038/nature05877 · Cited by 1,184
Self-citationSerhan, C. N. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141647 · Cited by 997
Cited by
Omega-3 polyunsaturated fatty acids and their health benefits
Shahidi, F., & Ambigaipalan, P. (2018) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-111317-095850 · Cited by 1,390
Impact of Obesity and Metabolic Syndrome on Immunity
Andersen, C. J., Murphy, K. E., & Fernandez, M. L. (2016) · Advances in Nutrition · doi:10.3945/an.115.010207 · Cited by 701
Domingueti, C. P., Dusse, L. M. S., Carvalho, M. D. G., de Sousa, L. P., Gomes, K. B., & Fernandes, A. P. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.12.018 · Cited by 647
Dalli, J., & Serhan, C. N. (2012) · Blood · doi:10.1182/blood-2012-04-423525 · Cited by 547
Oxidative stress and diabetes: antioxidative strategies
Zhang, P., Li, T., Wu, X., Nice, E. C., Huang, C., & Zhang, Y. (2020) · Frontiers of Medicine · doi:10.1007/s11684-019-0729-1 · Cited by 513
Resolvins, Specialized Proresolving Lipid Mediators, and Their Potential Roles in Metabolic Diseases
Spite, M., Clària, J., & Serhan, C. N. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.10.006 · Cited by 464
Health Benefits of n-3 Polyunsaturated Fatty Acids
Siriwardhana, N., Kalupahana, N. S., & Moustaid-Moussa, N. (2012) · Advances in Food and Nutrition Research · doi:10.1016/b978-0-12-416003-3.00013-5 · Cited by 367
Bioactive lipids, inflammation and chronic diseases
Leuti, A., Fazio, D., Fava, M., Piccoli, A., Oddi, S., & Maccarrone, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.028 · Cited by 358
Modulation of adipose tissue inflammation by bioactive food compounds
Siriwardhana, N., Kalupahana, N. S., Cekanova, M., LeMieux, M., Greer, B., & Moustaid-Moussa, N. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.12.013 · Cited by 345
Haufe, S., Engeli, S., Kast, P., Böhnke, J., Utz, W., Haas, V., Hermsdorf, M., Mähler, A., Wiesner, S., Birkenfeld, A. L., et al. (2011) · Hepatology · doi:10.1002/hep.24242 · Cited by 307
(n-3) Fatty Acids Alleviate Adipose Tissue Inflammation and Insulin Resistance: Mechanistic Insights
Kalupahana, N. S., Claycombe, K. J., & Moustaid-Moussa, N. (2011) · Advances in Nutrition · doi:10.3945/an.111.000505 · Cited by 305
“Moreover, transgenic restoration of (n-3) PUFA and protectin D1 prevents the high-fat-diet–induced insulin resistance, highlighting the important role of this DHA derivative (109).”
BackgroundHellmann, J., Tang, Y., Kosuri, M., Bhatnagar, A., & Spite, M. (2011) · The FASEB Journal · doi:10.1096/fj.10-178657 · Cited by 302
The role of non-resolving inflammation in atherosclerosis
Kasikara, C., Doran, A. C., Cai, B., & Tabas, I. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97950 · Cited by 266
Resolvin D1 and Resolvin D2 Govern Local Inflammatory Tone in Obese Fat
Clària, J., Dalli, J., Yacoubian, S., Gao, F., & Serhan, C. N. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201272 · Cited by 262
Weylandt, K. H., Chiu, C.-Y., Gomolka, B., Waechter, S. F., & Wiedenmann, B. (2012) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2012.01.005 · Cited by 258
Vandal, M., White, P. J., Tremblay, C., St-Amour, I., Chevrier, G., Emond, V., Lefrançois, D., Virgili, J., Planel, E., Giguere, Y., et al. (2014) · Diabetes · doi:10.2337/db14-0375 · Cited by 233
Self-citationNeuhofer, A., Zeyda, M., Mascher, D., Itariu, B. K., Murano, I., Leitner, L., Hochbrugger, E. E., Fraisl, P., Cinti, S., Serhan, C. N., et al. (2013) · Diabetes · doi:10.2337/db12-0828 · Cited by 229
Rotariu, D., Babes, E. E., Tit, D. M., Moisi, M., Bustea, C., Stoicescu, M., Radu, A.-F., Vesa, C. M., Behl, T., Bungau, A. F., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113238 · Cited by 225
Lipid signaling in adipose tissue: Connecting inflammation & metabolism
Masoodi, M., Kuda, O., Rossmeisl, M., Flachs, P., & Kopecky, J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.09.023 · Cited by 221
“tissue M Epididymal Endo Prevention of obesity-linked inflammation and IR [223] 508 M.”
BackgroundOmega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome
Martínez-Fernández, L., Laiglesia, L. M., Huerta, A. E., Martínez, J. A., & Moreno-Aliaga, M. J. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.07.003 · Cited by 212
Proresolution Therapy for the Treatment of Delayed Healing of Diabetic Wounds
Tang, Y., Zhang, M. J., Hellmann, J., Kosuri, M., Bhatnagar, A., & Spite, M. (2013) · Diabetes · doi:10.2337/db12-0684 · Cited by 204
Omega-3 Fatty Acids and Skeletal Muscle Health
Jeromson, S., Gallagher, I., Galloway, S., & Hamilton, D. (2015) · Marine Drugs · doi:10.3390/md13116977 · Cited by 203
Inflammation and resolution in obesity
Soták, M., Clark, M., Suur, B. E., & Börgeson, E. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01047-y · Cited by 198
Xue, B., Yang, Z., Wang, X., & Shi, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045990 · Cited by 179
Molecular Targets Related to Inflammation and Insulin Resistance and Potential Interventions
Hirabara, S. M., Gorjão, R., Vinolo, M. A., Rodrigues, A. C., Nachbar, R. T., & Curi, R. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/379024 · Cited by 178
Endo, J., Sano, M., Isobe, Y., Fukuda, K., Kang, J. X., Arai, H., & Arita, M. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132011 · Cited by 170
“…inflammatory diseases including colitis (Hudert et al., 2006), pancreatitis (Weylandt et al., 2008), osteoarthritis (Huang et al., 2012), atherosclerosis (Wan et al., 2010), obe-sity-linked insulin resistance (White et al., 2010), and some kinds of cancer (Xia et al., 2006; Weylandt et al., 2011).”
BackgroundSelf-citationZhuang, P., Li, H., Jia, W., Shou, Q., Zhu, Y., Mao, L., Wang, W., Wu, F., Chen, X., Wan, X., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01126-6 · Cited by 163
Flachs, P., Rossmeisl, M., Kuda, O., & Kopecky, J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.02.003 · Cited by 149
Pro-Resolving Mediators in Regulating and Conferring Macrophage Function
Dalli, J., & Serhan, C. N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01400 · Cited by 146
Macrophages, Meta-Inflammation, and Immuno-Metabolism
Shapiro, H., Lutaty, A., & Ariel, A. (2011) · The Scientific World JOURNAL · doi:10.1100/2011/397971 · Cited by 145
Insulin-sensitizing effects of omega-3 fatty acids: lost in translation?
Lalia, A., & Lanza, I. (2016) · Nutrients · doi:10.3390/nu8060329 · Cited by 141
“These bioactive lipid metabolites are, in general, associated with the resolution of obesity-linked inflammation and insulin resistance in high-fat fed mice [48].”
BackgroundOmega-3 long-chain polyunsaturated fatty acids: Metabolism and health implications
Khan, I. R., Hussain, M., Jiang, B., Zheng, L., Pan, Y., Hu, J., Khan, A., Ashraf, A., & Zou, X. (2023) · Progress in Lipid Research · doi:10.1016/j.plipres.2023.101255 · Cited by 140
Protectin DX alleviates insulin resistance by activating a myokine-liver glucoregulatory axis
White, P. J., St-Pierre, P., Charbonneau, A., Mitchell, P. L., St-Amand, E., Marcotte, B., & Marette, A. (2014) · Nature Medicine · doi:10.1038/nm.3549 · Cited by 131
Self-citationLópez-Vicario, C., González-Périz, A., Rius, B., Morán-Salvador, E., García-Alonso, V., Lozano, J. J., Bataller, R., Cofán, M., Kang, J. X., Arroyo, V., et al. (2014) · Gut · doi:10.1136/gutjnl-2012-303179 · Cited by 131
Self-citationProduction of fat-1 transgenic rats using a post-natal female germline stem cell line
Zhou, L., Wang, L., Kang, J. X., Xie, W., Li, X., Wu, C., Xu, B., & Wu, J. (2013) · Molecular Human Reproduction · doi:10.1093/molehr/gat081 · Cited by 131
Self-citationLópez‐Vicario, C., Rius, B., Alcaraz‐Quiles, J., García‐Alonso, V., Lopategi, A., Titos, E., & Clària, J. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.092 · Cited by 127
Fredman, G., Li, Y., Dalli, J., Chiang, N., & Serhan, C. N. (2012) · Scientific Reports · doi:10.1038/srep00639 · Cited by 122
Macrophage Proresolving Mediators—the When and Where
Dalli, J., & Serhan, C. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0001-2014 · Cited by 121
“…and potent anti-in fl ammatory and proresolving actions of resolvins, lipoxins, and maresins in vivo (36), new studies from others demonstrate their potent actions in experimental colitis (38), arthritis (39), arthritic pain ( 40), ocular diseases (41), and resolving obesity (42) and diabetes (43).”
BackgroundFlachs, P., Rühl, R., Hensler, M., Janovská, P., Zouhar, P., Kůs, V., Jílková, Z. M., Papp, E., Kuda, O., Svobodová, M., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2233-2 · Cited by 118
Heerwagen, M. J. R., Stewart, M. S., de la Houssaye, B. A., Janssen, R. C., & Friedman, J. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067791 · Cited by 110
Huang, C.-W., Chien, Y.-S., Chen, Y.-J., Ajuwon, K., Mersmann, H., & Ding, S.-T. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101689 · Cited by 100
Zhuang, P., Zhang, Y., Shou, Q., Li, H., Zhu, Y., He, L., Chen, J., & Jiao, J. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900946 · Cited by 101
Bidu, C., Escoula, Q., Bellenger, S., Spor, A., Galan, M., Geissler, A., Bouchot, A., Dardevet, D., Morio, B., Cani, P. D., et al. (2018) · Diabetes · doi:10.2337/db17-1488 · Cited by 90
The role of the tissue omega-6/omega-3 fatty acid ratio in regulating tumor angiogenesis
Kang, J. X., & Liu, A. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9401-9 · Cited by 90
Self-citationRole of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction
Lopategi, A., López‐Vicario, C., Alcaraz‐Quiles, J., García‐Alonso, V., Rius, B., Titos, E., & Clària, J. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.09.033 · Cited by 90
N-3 polyunsaturated fatty acids restore Th17 and Treg balance in collagen antibody-induced arthritis
Kim, J. Y., Lim, K., Kim, K. H., Kim, J. H., Choi, J. S., & Shim, S.-C. (2018) · PLOS ONE · doi:10.1371/journal.pone.0194331 · Cited by 86
Kim, E., Bae, J.-S., Hahm, K. B., & Cha, J.-Y. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.08.029 · Cited by 85
Kwon, Y. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900824 · Cited by 84
Bjursell, M., Xu, X., Admyre, T., Böttcher, G., Lundin, S., Nilsson, R. G., Stone, V. M., Morgan, N. G., Lam, Y. Y., Storlien, L. H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114942 · Cited by 81
Belchior, T., Paschoal, V. A., Magdalon, J., Chimin, P., Farias, T. M., Chaves‐Filho, A. B., Gorjão, R., St.‐Pierre, P., Miyamoto, S., Kang, J. X., et al. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400914 · Cited by 77
Self-citationLi, J., Li, F. R., Dong, W., Jia, W. P., Kang, J. X., Stefanović-Račić, M., Dai, Y., & Zhao, A. Z. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1011 · Cited by 75
Self-citationMolecular biology for formyl peptide receptors in human diseases
Li, Y., & Ye, D. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1005-5 · Cited by 71
Connaughton, R. M., McMorrow, A. M., McGillicuddy, F. C., Lithander, F. E., & Roche, H. M. (2016) · Proceedings of The Nutrition Society · doi:10.1017/s0029665116000070 · Cited by 71
Sato, H., Taketomi, Y., Miki, Y., Murase, R., Yamamoto, K., & Murakami, M. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107579 · Cited by 70
Pal, A., Al‐Shaer, A. E., Guesdon, W., Torres, M. J., Armstrong, M., Quinn, K. D., Davis, T., Reisdorph, N. A., Neufer, P. D., Spangenburg, E. E., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000830r · Cited by 68
Fish Oil Derived Omega 3 Fatty Acids Suppress Adipose NLRP3 Inflammasome Signaling in Human Obesity
Roberts-Lee, K., Midgette, Y. A., & Shah, R. D. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00220 · Cited by 65
Leukocytes from obese individuals exhibit an impaired SPM signature
López‐Vicario, C., Titos, E., Walker, M. E., Alcaraz‐Quiles, J., Casulleras, M., Duran‐Güell, M., Flores‐Costa, R., Pérez, N., Forné, M., Dalli, J., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802587r · Cited by 65
Horn, S. S., Sonesson, A. K., Krasnov, A., Moghadam, H. K., Hillestad, B., Meuwissen, T. H. E., & Ruyter, B. (2019) · Scientific Reports · doi:10.1038/s41598-019-40391-2 · Cited by 64
Nutrients, Physical Activity, and Mitochondrial Dysfunction in the Setting of Metabolic Syndrome
Lemos, G., Torrinhas, R. S., & Waitzberg, D. L. (2023) · Nutrients · doi:10.3390/nu15051217 · Cited by 63
Skeletal muscle glucose metabolism and inflammation in the development of the metabolic syndrome
Marette, A., Liu, Y., & Sweeney, G. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9296-6 · Cited by 63
Self-citationBellenger, J., Bellenger, S., Escoula, Q., Bidu, C., & Narce, M. (2019) · Biochimie · doi:10.1016/j.biochi.2019.01.017 · Cited by 61
Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid
Beyer, M. P., Videla, L. A., Farías, C., & Valenzuela, R. (2023) · Nutrients · doi:10.3390/nu15153317 · Cited by 59
White, P. J., Mitchell, P. L., Schwab, M. G., Trottier, J., Kang, J., Barbier, O., & Marette, A. (2015) · Metabolism · doi:10.1016/j.metabol.2015.01.017 · Cited by 58
Self-citationThe Effects of Omega 3 and Omega 6 Fatty Acids on Glucose Metabolism: An Updated Review
Egalini, F., Guardamagna, O., Gaggero, G., Varaldo, E., Giannone, B., Beccuti, G., Benso, A. S., & Broglio, F. (2023) · Nutrients · doi:10.3390/nu15122672 · Cited by 58
Omega-3-derived mediators counteract obesity-induced adipose tissue inflammation
Titos, E., & Clària, J. (2013) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2013.05.003 · Cited by 57
Pro-resolving actions of SPM in adipose tissue biology
Clària, J., López‐Vicario, C., Rius, B., & Titos, E. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.03.004 · Cited by 52
Lipoxins as biomarkers of lupus and other inflammatory conditions
Das, U. N. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-76 · Cited by 52
Masi, L. N., Martins, A. R., Neto, J. C. R., do Amaral, C. L., Crisma, A. R., Vinolo, M. A. R., Júnior, E. A. D. L., Hirabara, S. M., & Curi, R. (2012) · BioMed Research International · doi:10.1155/2012/945131 · Cited by 51
Ferguson, J. F., Roberts-Lee, K., Borcea, C., Smith, H., Midgette, Y. A., & Shah, R. D. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.09.027 · Cited by 51
Boer, A. A. D., Monk, J. M., Liddle, D. M., Hutchinson, A. L., Power, K. A., David, W. L., & Robinson, L. E. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.04.004 · Cited by 51
Liddle, D. M., Hutchinson, A. L., Wellings, H. R., Power, K. A., Robinson, L. E., & Monk, J. M. (2017) · Nutrients · doi:10.3390/nu9121289 · Cited by 50
Specialized Proresolving Mediators: Enhancing Nonalcoholic Steatohepatitis and Fibrosis Resolution
Musso, G., Gambino, R., Cassader, M., Paschetta, E., & Sircana, A. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.01.003 · Cited by 47
Park, S., Lee, J., Lee, J., Lee, J. K., Byun, J., Kim, I., & Ha, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126384 · Cited by 47
Proresolving lipid mediators and diabetic wound healing
Hellmann, J. L., Tang, Y., & Spite, M. R. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283514e00 · Cited by 47
Wang, T., Yang, B., Ji, R., Xu, W., Mai, K., & Ai, Q. (2017) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2017.09.064 · Cited by 47
Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes
Sima, C., Paster, B. J., & Dyke, T. E. V. (2018) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2018026750 · Cited by 45
Romanatto, T., Fiamoncini, J., Wang, B., Curi, R., & Kang, J. X. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.10.017 · Cited by 42
Self-citationKhanna, N. N., Maindarkar, M. A., Viswanathan, V., Puvvula, A., Paul, S., Bhagawati, M., Ahluwalia, P., Ruzsa, Z., Sharma, A., Kolluri, R., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11226844 · Cited by 41
Woo, S. J., Lim, K., Park, S., Jung, M. Y., Lim, H. S., Jeon, M.-G., Lee, S.-I., & Park, B. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.01.011 · Cited by 40
Sucrose, fructose, glucose, and their link to metabolic syndrome and cancer
Das, U. N. (2014) · Nutrition · doi:10.1016/j.nut.2014.05.015 · Cited by 40
Gart, E., Salic, K., Morrison, M. C., Caspers, M. P. M., van Duyvenvoorde, W., Heijnk, M., Giera, M. A., Bobeldijk‐Pastorova, I., Keijer, J., Storsve, A. B., et al. (2021) · Nutrients · doi:10.3390/nu13082836 · Cited by 40
Schulte, F., Asbeutah, A. A., Benotti, P. N., Wood, G. C., Still, C. D., Bistrian, B. R., Hardt, M., & Welty, F. K. (2020) · Scientific Reports · doi:10.1038/s41598-020-75353-6 · Cited by 40
The Omega-6/Omega-3 Fatty Acid Ratio in Chronic Diseases: Animal Models and Molecular Aspects
Kang, J. X. (2011) · World review of nutrition and dietetics · doi:10.1159/000327787 · Cited by 39
Self-citationAstarita, G., McKenzie, J. H., Wang, B., Strassburg, K., Doneanu, A., Johnson, J. S., Baker, A., Hankemeier, T., Murphy, J., Vreeken, R. J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096221 · Cited by 39
Self-citationFiamoncini, J., Turner, N. A., Hirabara, S. M., Salgado, T. M., Marçal, A. C., Leslie, S. J., Silva, S. M. A., Deschamps, F. C., Luz, J., Cooney, G. J., et al. (2013) · Obesity · doi:10.1002/oby.20132 · Cited by 36
Sandhu, N., Schetter, S. E., Liao, J., Hartman, T. J., Richie, J. P., McGinley, J. N., Thompson, H. J., Prokopczyk, B., DuBrock, C., Signori, C., et al. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0235 · Cited by 35
Tang, R., Harasymowicz, N. S., Wu, C., Choi, Y., Lenz, K. L., Oswald, S. J., & Guilak, F. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2402954121 · Cited by 35
Escoula, Q., Bellenger, S., Narce, M., & Bellenger, J. (2019) · Nutrients · doi:10.3390/nu11092179 · Cited by 34
Miao, Z., Schultzberg, M., Wang, X., & Zhao, Y. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2020.12.037 · Cited by 34
Song, M., Wang, J., Lee, Y., Lee, J. H., Kwon, K.-S., Bae, E. J., & Park, B. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600014 · Cited by 34
Lipid mediators of inflammation in obesity-related glomerulopathy
Nolan, E. F., O’Meara, Y., & Godson, C. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft392 · Cited by 33
Obesity, immunomodulation and chronic kidney disease
Börgeson, E., & Sharma, K. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.05.011 · Cited by 32
Bioactive Oxylipins Profile in Marine Microalgae
Linares-Maurizi, A., Réversat, G., Awad, R., Bultel‐Poncé, V., Oger, C., Galano, J., Balas, L., Durbec, A., Bertrand‐Michel, J., Durand, T., et al. (2023) · Marine Drugs · doi:10.3390/md21030136 · Cited by 31
Role and mechanism of specialized pro-resolving mediators in obesity-associated insulin resistance
Liu, X., Tang, Y., Luo, Y., Gao, Y., & He, L. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02207-9 · Cited by 31
Colson, C., Ghandour, R. A., Dufies, O., Rekima, S., Loubat, A., Munro, P. M., Boyer, L., & Pisani, D. F. (2019) · Nutrients · doi:10.3390/nu11020438 · Cited by 29
López‐Vicario, C., Sebastián, D., Casulleras, M., Duran‐Güell, M., Flores‐Costa, R., Aguilar, F., Lozano, J. J., Zhang, I. W., Titos, E., Kang, J. X., et al. (2022) · Hepatology · doi:10.1002/hep.32647 · Cited by 29
Self-citationPotential role of omega‐3‐derived resolution mediators in metabolic inflammation
White, P. J., & Marette, A. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2013.112 · Cited by 29
Self-citationLiu, M., Montgomery, M. K., Fiveash, C. E., Osborne, B., Cooney, G. J., Bell-Anderson, K. S., & Turner, N. A. (2014) · Scientific Reports · doi:10.1038/srep05538 · Cited by 26
Hao, L., Chen, C., Nie, Y.-H., Kaliannan, K., & Kang, J. X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417261 · Cited by 25
Self-citationfat-1 mice prevent high-fat plus high-sugar diet-induced non-alcoholic fatty liver disease
Guo, X., Gao, J., Li, J., & Li, D. (2017) · Food & Function · doi:10.1039/c7fo01050h · Cited by 25
Metadata
- Authors
- White, P. J., Arita, M., Taguchi, R., Kang, J. X., & Marette, A.
- Affiliations
- Centre hospitalier universitaire de Québec (CA)
- The University of Tokyo (JP)
- Harvard University (US)
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Corresponding author
- Marette, André
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2010-09-14
- Volume
- 59
- Issue
- 12
- Pages
- 3066-3073
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2992767
- OpenAlex
- W2098208341
- Cited by
- 185
- References
- 33
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 8 · 2023: 10 · 2022: 10 · 2021: 14 · 2020: 13 · 2019: 9 · 2018: 11 · 2017: 14 · 2016: 15 · 2015: 13 · 2014: 21 · 2013: 18 · 2012: 15
- FWCI
- 12.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (21370051)
- National Cancer Institute (R01CA113605)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- omega-3 fatty acids, inflammation resolution, protectin D1, docosanoids, obesity, insulin resistance, high-fat diet, adipose tissue macrophages, skeletal muscle, adipose tissue, inducible nitric oxide synthase, JNK, transgenic mice, chronic inflammation
- MeSH terms
- Animals, Dietary Fats, Fatty Acids, Inflammation, Insulin Resistance, Lipids, Male, Mice, Transgenic, Obesity, Tumor Necrosis Factor-alpha, Fatty Acids, Omega-3, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.